title: Intestinal microsporidiosis due to Enterocytozoon bieneusi in a pediatric kidney transplant recipient successfully treated with fumagillin.
authors.affiliation: 1 Centre Hospitalier Universitaire de Bordeaux Service de Pédiatrie, Centre de Référence Maladies Rénales Rares du Sud-Ouest Hôpital Pellegrin-Enfants Bordeaux, France 2 Centre Hospitalier Universitaire de Bordeaux Service de Parasitologie et Mycologie Hôpital Saint André Bordeaux, France 3 Centre Hospitalier Universitaire de Bordeaux Pharmacie, Hôpital Pellegrin Bordeaux, FranceSanofi-Aventis France provided the drug for this patient.
authors.forename: Astrid
authors.initials: A
authors.lastname: Godron
authors.forename: Isabelle
authors.initials: I
authors.lastname: Accoceberry
authors.forename: Axelle
authors.initials: A
authors.lastname: Couret
authors.forename: Brigitte
authors.initials: B
authors.lastname: Llanas
authors.forename: Jérôme
authors.initials: J
authors.lastname: Harambat
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D002648:Child; D003510:Cyclohexanes / Q000627:therapeutic use*; D021862:Enterocytozoon; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D016881:Microsporidiosis / Q000188:drug therapy*; D012717:Sesquiterpenes / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; C026211:fumagillin